Development of a novel modified vaccine (TheraVac) for curative treatment of mouse solid tumors.
Monotherapy with immune checkpoint blockade (ICB) antibodies (anti-CTLA4 and anti-PD1/PDL-1) is only effective for 20% to 30% of patients with certain cancers. Patients with cancers harborin...